{"name":"Vastra Gotaland Region","slug":"vastra-gotaland-region","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"clofarabine, fludarabine and busulfan, CloFluBu","genericName":"clofarabine, fludarabine and busulfan, CloFluBu","slug":"clofarabine-fludarabine-and-busulfan-cloflubu","indication":"Conditioning regimen for hematopoietic stem cell transplantation in acute leukemias and lymphomas","status":"phase_3"},{"name":"Anti-VEGF treatment","genericName":"Anti-VEGF treatment","slug":"anti-vegf-treatment","indication":"Metastatic colorectal cancer","status":"phase_2"},{"name":"Capecitabine, Cyclophosphamide","genericName":"Capecitabine, Cyclophosphamide","slug":"capecitabine-cyclophosphamide","indication":"Metastatic breast cancer","status":"phase_2"},{"name":"IPI1/NIVO3","genericName":"IPI1/NIVO3","slug":"ipi1-nivo3","indication":"Advanced or metastatic melanoma","status":"phase_3"},{"name":"IPI3/NIVO1","genericName":"IPI3/NIVO1","slug":"ipi3-nivo1","indication":"Advanced or metastatic melanoma","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"cardiovascular","drugs":[{"name":"Bisoprolol Oral Tablet","genericName":"Bisoprolol Oral Tablet","slug":"bisoprolol-oral-tablet","indication":"Other","status":"marketed"},{"name":"Dapagliflozin Oral Product","genericName":"Dapagliflozin Oral Product","slug":"dapagliflozin-oral-product","indication":"Other","status":"marketed"},{"name":"Dipyridamole 200 mg","genericName":"Dipyridamole 200 mg","slug":"dipyridamole-200-mg","indication":"Other","status":"marketed"},{"name":"Progesterone vaginal tablet","genericName":"Progesterone vaginal tablet","slug":"progesterone-vaginal-tablet","indication":"Other","status":"marketed"},{"name":"Ramipril Oral Product","genericName":"Ramipril Oral Product","slug":"ramipril-oral-product","indication":"Other","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dry plasma","genericName":"Dry plasma","slug":"dry-plasma","indication":"Acute bleeding and coagulation factor deficiency","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Randomisation course 2 ADxE versus FLADx","genericName":"Randomisation course 2 ADxE versus FLADx","slug":"randomisation-course-2-adxe-versus-fladx","indication":"Treatment of various autoimmune diseases","status":"phase_3"}]}],"pipeline":[{"name":"Dry plasma","genericName":"Dry plasma","slug":"dry-plasma","phase":"marketed","mechanism":"Dry plasma is a lyophilized (freeze-dried) blood plasma product that restores coagulation factors and other plasma proteins when reconstituted.","indications":["Acute bleeding and coagulation factor deficiency","Perioperative hemostasis support","Massive transfusion protocols"],"catalyst":""},{"name":"clofarabine, fludarabine and busulfan, CloFluBu","genericName":"clofarabine, fludarabine and busulfan, CloFluBu","slug":"clofarabine-fludarabine-and-busulfan-cloflubu","phase":"phase_3","mechanism":"CloFluBu is a combination chemotherapy regimen that inhibits DNA synthesis and repair through three nucleoside analogs, used as a myeloablative conditioning regimen prior to hematopoietic stem cell transplantation.","indications":["Conditioning regimen for hematopoietic stem cell transplantation in acute leukemias and lymphomas"],"catalyst":""},{"name":"Anti-VEGF treatment","genericName":"Anti-VEGF treatment","slug":"anti-vegf-treatment","phase":"phase_2","mechanism":"Anti-VEGF treatment works by inhibiting the vascular endothelial growth factor (VEGF) pathway, which is involved in angiogenesis and tumor growth.","indications":["Metastatic colorectal cancer","Metastatic non-small cell lung cancer","Metastatic renal cell carcinoma"],"catalyst":""},{"name":"Bisoprolol Oral Tablet","genericName":"Bisoprolol Oral Tablet","slug":"bisoprolol-oral-tablet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Capecitabine, Cyclophosphamide","genericName":"Capecitabine, Cyclophosphamide","slug":"capecitabine-cyclophosphamide","phase":"phase_2","mechanism":"Capecitabine is a prodrug that is converted into 5-fluorouracil, which interferes with DNA synthesis, thereby inhibiting cancer cell growth. Cyclophosphamide is an alkylating agent that attaches an alkyl group to the DNA of cancer cells, thereby interfering with their replication.","indications":["Metastatic breast cancer","Advanced colorectal cancer"],"catalyst":""},{"name":"Dapagliflozin Oral Product","genericName":"Dapagliflozin Oral Product","slug":"dapagliflozin-oral-product","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Dipyridamole 200 mg","genericName":"Dipyridamole 200 mg","slug":"dipyridamole-200-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"IPI1/NIVO3","genericName":"IPI1/NIVO3","slug":"ipi1-nivo3","phase":"phase_3","mechanism":"IPI1/NIVO3 is a combination of an inducible T-cell co-stimulator (ICOS) agonist and a PD-1 inhibitor that enhances anti-tumor immune responses by activating T cells while removing inhibitory checkpoint signals.","indications":["Advanced or metastatic melanoma","Non-small cell lung cancer"],"catalyst":""},{"name":"IPI3/NIVO1","genericName":"IPI3/NIVO1","slug":"ipi3-nivo1","phase":"phase_3","mechanism":"IPI3/NIVO1 is a combination of an inducible T-cell co-stimulator (ICOS) agonist and a PD-1 inhibitor that enhances anti-tumor immune responses by activating T cells while removing inhibitory checkpoint signals.","indications":["Advanced or metastatic melanoma","Non-small cell lung cancer"],"catalyst":""},{"name":"Progesterone vaginal tablet","genericName":"Progesterone vaginal tablet","slug":"progesterone-vaginal-tablet","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ramipril Oral Product","genericName":"Ramipril Oral Product","slug":"ramipril-oral-product","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Randomisation course 2 ADxE versus FLADx","genericName":"Randomisation course 2 ADxE versus FLADx","slug":"randomisation-course-2-adxe-versus-fladx","phase":"phase_3","mechanism":"ADxE and FLADx are both involved in the regulation of the immune system.","indications":["Treatment of various autoimmune diseases"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5PM1JQSUJPNEpKMnJ2MG1iOXlyXzZodTd4enpRM0NKSEZqN1NZVHVPbEN5Z19SZXhYZEZBYUU5TldBcFRLZDdwTkxuWHBrMXJFU09FNkJtbU91cEd2Tmgw?oc=5","date":"2025-10-30","type":"pipeline","source":"nature.com","summary":"Exploring predictors of post-COVID-19 condition among 810 851 individuals in Sweden | Communications Medicine - nature.com","headline":"Exploring predictors of post-COVID-19 condition among 810 851 individuals in Sweden | Communications Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQMEppWU05MHk5NGZtdXFpbkYxaHk5QS1nQm96ZVZackZOOFM2ZDlzUWd1REp4RjJnZ19uVG00ZnB2MFJlUGFMMUtFeVFsdVR3YmU1QUF1Y1d0VUdHTkF2S3NsbVdyRUxCamJmVUFodEpxNXQwOTBJSGJQT2UxX1ZkUWJ5Q2xoUDdWZHJub1JJajFmWmo4MFFNQ3JYZFNldzQ3S2t3N3ZQc3FPS3NmS3FabUwzYllQUm5rTm5STjlubFMzdE1NeTRvdGFPRFZnWlB0ZnlpeTBTZEVFeGFia3p0Q1VlZUR1aktKU1YyVG1UTEJYQTZmdzd6aFFqSElfRldwcEs0UDViTjJQUkhOWnNJYjdSVEltcTJhSUxfSzJtTW5jWnZW?oc=5","date":"2025-07-02","type":"pipeline","source":"Mynewsdesk","summary":"Distinguished Swedish Investors Back Leading Biotech Company in GoCo Health Innovation City to Advance siRNA Therapies - Mynewsdesk","headline":"Distinguished Swedish Investors Back Leading Biotech Company in GoCo Health Innovation City to Advance siRNA Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPOVVvRGhpUHB6bU9PamJrOVlvOTFtaG8tYWt2anlWS2p3Y1VTNEtRa3VBYnpTU25fLTB1ekw0NTRJQnk5OVJGM1EyQkVkX3NDNFZEMTJXSVhKREVhSnByWTROTWszTEJISmVoUFlCcktkMC1hUE96T1JvdENzOUQzZUZuVF8yV0l0d1BWS3BKckRscTJhaVNWNmVKMkEzeDhXbVBmQg?oc=5","date":"2025-03-03","type":"pipeline","source":"Göteborgs universitet","summary":"The Region's Engagement in Life Science and WCMTM – An Investment in the Future - Göteborgs universitet","headline":"The Region's Engagement in Life Science and WCMTM – An Investment in the Future - Göteborgs universitet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5GVGxuUE9PRWFnSGY5QWFTdEpCWUV0YUY2cXBla3BPZEw2YzdrUXBLQkUzSnpWVEhLWEtfN0o5YVNHVEVqT2E3SEV5Rm9PQVVWVGlkbnBVdUd4Y1FiWGpJ?oc=5","date":"2024-12-06","type":"pipeline","source":"nature.com","summary":"Analysis of queries to a Swedish drug information centre identifies scientific knowledge gaps - nature.com","headline":"Analysis of queries to a Swedish drug information centre identifies scientific knowledge gaps","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNZHQ1RjlwMGxfNDRIdnZvQ0lYcWZTXzc2S2JQekU1M3VqSzBCZ2FBQTl4alZKc2djazZDVTZLR1BiME55V2xYWllOSUdhQVFfSEdVOTNpc2JwNVpNMm84M1c0RG9iYnJvcnlTQUw3c3otcm56ZGVTckZud1N0M3J3MGt1ZGdUR1hyTDBadHlhaXVRZjRFaWczNEdLSnBTXzh4SE4zaDAtdmFYM3c1c1ZndE1BdnZNS09vVVRKbWtDVVc?oc=5","date":"2024-01-12","type":"deal","source":"Göteborgs universitet","summary":"Collaboration with Region Västra Götaland | University of Gothenburg - Göteborgs universitet","headline":"Collaboration with Region Västra Götaland | University of Gothenburg - Göteborgs universitet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9Cai1hS3NuTWVWeExCOG1DMDBMdFFoZGg0c0I2cGN6QWs1eGxlc2JPU050Ynk5NHFBR0RTSmJmYWg5UWtuMTdfQXN5UGFjZW5JOURqTjhBd1VxYzdnbnc?oc=5","date":"2022-01-28","type":"trial","source":"Akademiliv","summary":"Gothia Forum can help you with your clinical study – for free or at cost - Akademiliv","headline":"Gothia Forum can help you with your clinical study – for free or at cost","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNZHU0a1Y3RVFlSk9kS3ZvMFZjeTRxbFBIRVpGMWFtSElwVTJoZlJEb3RFS3hGbm9PNmlqdUhJRUNyd0lPSUxib3AwRXpFNXFyd0M3RFFVd3BtZUJFc1pJc3FWb19GejBJZGhUWnhHZ3dKZ0EzZWJFdHhQRGQtWW15SVBrem1nQnVZVGRiNzJwT2Y?oc=5","date":"2018-04-10","type":"pipeline","source":"Railway Technology","summary":"Bombardier to provide 40 high-speed trains to Sweden - Railway Technology","headline":"Bombardier to provide 40 high-speed trains to Sweden","sentiment":"neutral"}],"patents":[],"drugCount":12,"phaseCounts":{"marketed":6,"phase_3":4,"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}